合計 50 件の最近のインサイダー取引記録が記録されています Structure Therapeutics Inc. (GPCR), 内訳は 28 件の買い および 22 件の売り. インサイダー買い総額は $22.67M インサイダー売り総額は $3.19M.
最近活動のある主要インサイダーには Stevens Raymond C, Hall Ashley, Yoon Jun. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — GPCR
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-19 |
Stevens Raymond C |
Chief Executive Officer |
RSU 付与（制限付株式） |
322,230 |
$16.82 |
$5.42M |
322,230 |
| 2026-03-19 |
Hall Ashley |
Chief Development Officer |
RSU 付与（制限付株式） |
59,073 |
$16.82 |
$993.61K |
59,073 |
| 2026-03-19 |
Yoon Jun |
Chief Financial Officer |
RSU 付与（制限付株式） |
128,892 |
$16.82 |
$2.17M |
128,892 |
| 2026-03-19 |
Lin Xichen |
Chief Scientific Officer |
RSU 付与（制限付株式） |
53,703 |
$16.82 |
$903.28K |
53,703 |
| 2026-03-19 |
Ma Yingli |
Chief Technology Officer |
RSU 付与（制限付株式） |
40,278 |
$16.82 |
$677.48K |
40,278 |
| 2026-03-19 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 付与（制限付株式） |
93,984 |
$16.82 |
$1.58M |
93,984 |
| 2026-03-03 |
Stevens Raymond C |
Chief Executive Officer |
RSU 源泉徴収 |
53,454 |
$20.99 |
$1.12M |
1,141,376 |
| 2026-03-03 |
Hall Ashley |
Chief Development Officer |
RSU 源泉徴収 |
4,836 |
$20.99 |
$101.51K |
107,481 |
| 2026-03-03 |
Yoon Jun |
Chief Financial Officer |
RSU 源泉徴収 |
22,305 |
$20.99 |
$468.18K |
1,297,571 |
| 2026-03-03 |
Lin Xichen |
Chief Scientific Officer |
RSU 源泉徴収 |
18,735 |
$20.99 |
$393.25K |
185,592 |
| 2026-03-03 |
Ma Yingli |
Chief Technology Officer |
RSU 源泉徴収 |
11,313 |
$20.99 |
$237.46K |
107,391 |
| 2026-03-03 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 源泉徴収 |
11,826 |
$20.99 |
$248.23K |
204,981 |
| 2026-01-15 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
情報に基づく売り |
20 |
- |
- |
4,103 |
| 2025-12-08 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
情報に基づく売り |
15,535 |
- |
- |
- |
| 2025-11-20 |
Stevens Raymond C |
Chief Executive Officer |
RSU 付与（制限付株式） |
824 |
- |
- |
1,824 |
| 2025-11-20 |
Hall Ashley |
Chief Development Officer |
RSU 付与（制限付株式） |
237 |
- |
- |
462 |
| 2025-09-18 |
Hall Ashley |
Chief Development Officer |
RSU 源泉徴収 |
6,021 |
$7.74 |
$46.62K |
112,317 |
| 2025-09-18 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 源泉徴収 |
8,106 |
$7.74 |
$62.77K |
216,807 |
| 2025-07-30 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
情報に基づく売り |
26,310 |
- |
- |
1,515,558 |
| 2025-07-01 |
Lin Xichen |
Chief Scientific Officer |
RSU 源泉徴収 |
12,846 |
$6.84 |
$87.82K |
204,327 |
| 2025-07-01 |
Ma Yingli |
Chief Technology Officer |
RSU 源泉徴収 |
4,470 |
$6.84 |
$30.56K |
118,704 |
| 2025-07-01 |
Stevens Raymond C |
Chief Executive Officer |
RSU 源泉徴収 |
16,050 |
$6.84 |
$109.73K |
1,194,830 |
| 2025-07-01 |
Yoon Jun |
Chief Financial Officer |
RSU 源泉徴収 |
7,089 |
$6.84 |
$48.46K |
1,319,876 |
| 2025-07-01 |
Lin Xichen |
Chief Scientific Officer |
RSU 付与（制限付株式） |
57,078 |
- |
- |
217,173 |
| 2025-07-01 |
Ma Yingli |
Chief Technology Officer |
RSU 付与（制限付株式） |
24,459 |
- |
- |
123,174 |
| 2025-07-01 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 源泉徴収 |
1,434 |
$6.84 |
$9.8K |
224,913 |
| 2025-06-23 |
Love Ted W |
Director |
RSU 付与（制限付株式） |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Dobmeier Eric |
Director |
RSU 付与（制限付株式） |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Welch Daniel G |
Director |
RSU 付与（制限付株式） |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Tetlow Sharon |
Director |
RSU 付与（制限付株式） |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-06-23 |
Russell Angus C. |
Director |
RSU 付与（制限付株式） |
42,833 |
$7.37 |
$315.68K |
42,833 |
| 2025-06-23 |
Waldstreicher Joanne |
Director |
RSU 付与（制限付株式） |
51,804 |
$7.37 |
$381.8K |
51,804 |
| 2025-05-21 |
Stevens Raymond C |
Chief Executive Officer |
RSU 付与（制限付株式） |
1,000 |
- |
- |
1,000 |
| 2025-05-21 |
Yoon Jun |
Chief Financial Officer |
RSU 付与（制限付株式） |
831 |
- |
- |
2,946 |
| 2025-05-21 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 付与（制限付株式） |
429 |
- |
- |
1,157 |
| 2025-05-20 |
Hall Ashley |
Chief Development Officer |
RSU 付与（制限付株式） |
225 |
- |
- |
225 |
| 2025-03-15 |
Stevens Raymond C |
Chief Executive Officer |
RSU 付与（制限付株式） |
826,890 |
$7.02 |
$5.8M |
826,890 |
| 2025-03-15 |
Hall Ashley |
Chief Development Officer |
RSU 付与（制限付株式） |
51,048 |
- |
- |
118,338 |
| 2025-03-15 |
Yoon Jun |
Chief Financial Officer |
RSU 付与（制限付株式） |
413,445 |
$7.02 |
$2.9M |
413,445 |
| 2025-03-15 |
Lin Xichen |
Chief Scientific Officer |
RSU 付与（制限付株式） |
80,829 |
- |
- |
166,536 |
| 2025-03-15 |
Ma Yingli |
Chief Technology Officer |
RSU 付与（制限付株式） |
63,810 |
- |
- |
100,539 |
| 2025-03-15 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 付与（制限付株式） |
116,988 |
- |
- |
219,588 |
| 2025-03-01 |
Stevens Raymond C |
Chief Executive Officer |
RSU 源泉徴収 |
12,495 |
$7.92 |
$98.92K |
1,121,183 |
| 2025-03-01 |
Yoon Jun |
Chief Financial Officer |
RSU 源泉徴収 |
5,940 |
$7.92 |
$47.02K |
1,287,359 |
| 2025-03-01 |
Lin Xichen |
Chief Scientific Officer |
RSU 源泉徴収 |
6,441 |
$7.92 |
$50.99K |
160,095 |
| 2025-03-01 |
Ma Yingli |
Chief Technology Officer |
RSU 源泉徴収 |
1,824 |
$7.92 |
$14.44K |
98,715 |
| 2025-03-01 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 源泉徴収 |
1,233 |
$7.92 |
$9.76K |
218,355 |
| 2025-02-06 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
情報に基づく売り |
41 |
- |
- |
- |
| 2024-11-20 |
Yoon Jun |
Chief Financial Officer |
RSU 付与（制限付株式） |
821 |
- |
- |
2,115 |
| 2024-11-20 |
Coll Crespo Blas |
Chief Medical Officer |
RSU 付与（制限付株式） |
363 |
- |
- |
728 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
